UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?

UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?

Pokaži ostale verzije (1)

BACKGROUND AND PURPOSE: A UK government review recommended that the impact of disease on the population and economy should be assessed to inform health research priorities. This study aims to quantify UK governmental and charity research funding for dementia, cancer, coronary heart disease (CHD) an...

Bibliografski detalji
Glavni autori:	Luengo-Fernandez, R, Leal, J, Gray, A
Format:	Journal article
Jezik:	English
Izdano:	2012

Slični predmeti

UK research expenditure on dementia, heart disease, stroke and cancer: Are levels of spending related to disease burden?
od: Luengo-Fernandez, R, i dr.
Izdano: (2012)

The economic burden of cancer, coronary heart disease, dementia and stroke in England in 2018: an evaluation of two cohort studies
od: Landeiro, F, i dr.
Izdano: (2024)

The economic burden of coronary heart disease in the UK.
od: Liu, J, i dr.
Izdano: (2002)

Economic burden of cardiovascular diseases in the enlarged European Union.
od: Leal, J, i dr.
Izdano: (2006)

Economic burden of cardiovascular disease in the enlarged European Union
od: Leal, J, i dr.
Izdano: (2006)

Economic burden of cardiovascular diseases in the European Union: a population-based cost study
od: Luengo-Fernandez, R, i dr.
Izdano: (2023)

Economic burden of stroke across Europe: a population-based cost analysis
od: Luengo-Fernandez, R, i dr.
Izdano: (2019)

Cost of dementia in the pre-enlargement countries of the European Union.
od: Luengo-Fernandez, R, i dr.
Izdano: (2011)

Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries
od: Luengo-Fernandez, R, i dr.
Izdano: (2023)

Economic burden of cancer across the European Union: A population-based cost analysis
od: Luengo-Fernandez, R, i dr.
Izdano: (2013)

Economic burden of cancer across the European Union: a population-based cost analysis.
od: Luengo-Fernandez, R, i dr.
Izdano: (2013)

Economic burden of bladder cancer across the European Union
od: Leal, J, i dr.
Izdano: (2015)

Cost of cardiovascular diseases in the United Kingdom.
od: Luengo-Fernández, R, i dr.
Izdano: (2006)

The high cost of not funding stroke research: a comparison with heart disease and cancer.
od: Rothwell, P
Izdano: (2001)

Acute costs of stroke in the UK National Health Service in 2002-2004
od: Luengo-Fernandez, R, i dr.
Izdano: (2004)

Social isolation and risk of heart disease and stroke: two large UK prospective studies
od: Smith, R, i dr.
Izdano: (2021)

Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
od: Nichols, E, i dr.
Izdano: (2018)

Economic burden of CVD across the European Union: trends over the last decade
od: Leal, J, i dr.
Izdano: (2017)

Costs of stroke using patient-level data: a critical review of the literature.
od: Luengo-Fernandez, R, i dr.
Izdano: (2009)

TRENDS IN THE BURDEN OF CARDIOVASCULAR DISEASES IN THE UK, 1961 TO 2011
od: Bhatnagar, P, i dr.
Izdano: (2011)

Abstract TP22: delirium, infection, and risk of dementia in patients with and without cerebral small vessel disease
od: Luengo-Fernandez, R, i dr.
Izdano: (2024)

Homocysteine and prediction of coronary heart disease and stroke
od: Clarke, R, i dr.
Izdano: (2003)

Burden of Stroke in Europe: An Analysis of the Global Burden of Disease Study Findings From 2010 to 2019
od: Prendes, CF, i dr.
Izdano: (2024)

Global burden of Alzheimer’s disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the global burden of disease study 2021
od: Zhang, X, i dr.
Izdano: (2024)

Dementia and hospital admission post-TIA and stroke: longitudinal population-based study
od: Pendlebury, ST, i dr.
Izdano: (2019)

Economic burden of non-malignant blood disorders across Europe: A population-based cost study
od: Luengo-Fernandez, R, i dr.
Izdano: (2016)

Temporal trends (2002-2012) in long-term outcome and quality-adjusted life-expectancy after incident stroke in Oxfordshire, UK: evidence of impact of acute stroke care at the population-level
od: Luengo-Fernandez, R, i dr.
Izdano: (2018)

SpendView : a platform for democratizing access to government budget and expenditure data
od: Aristarán, Manuel
Izdano: (2016)

A burden of proof study on alcohol consumption and ischemic heart disease
od: Carr, S, i dr.
Izdano: (2024)

Homocysteine-lowering trials for prevention of heart disease and stroke.
od: Clarke, R
Izdano: (2005)

Stroke, coronary heart disease, cholesterol and blood pressure
od: Lewington, S, i dr.
Izdano: (1997)

Dementia in Parkinson’s disease
od: Hu, M, i dr.
Izdano: (2020)

Sickle cell disease in Africa: burden and research priorities.
od: Makani, J, i dr.
Izdano: (2007)

Economic burden of malignant blood disorders across Europe: A population-based cost analysis
od: Burns, R, i dr.
Izdano: (2016)

Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.
od: Feigin, V, i dr.
Izdano: (2014)

Aid, public expenditure, and Dutch disease.
od: Adam, C, i dr.
Izdano: (2003)

Aid, public expenditure and Dutch disease
od: Adam, C
Izdano: (2003)

UK health performance: findings of the Global Burden of Disease Study 2010.
od: Murray, C, i dr.
Izdano: (2013)

UK health performance: Findings of the Global Burden of Disease Study 2010
od: Murray, C, i dr.
Izdano: (2013)

Hypertension in pregnancy and risk of coronary heart disease and stroke: a prospective study in a large UK cohort
od: Canoy, D, i dr.
Izdano: (2016)